1. Home
  2. NPO vs PTCT Comparison

NPO vs PTCT Comparison

Compare NPO & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enpro Inc.

NPO

Enpro Inc.

HOLD

Current Price

$315.71

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$68.52

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPO
PTCT
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.5B
IPO Year
2002
2006

Fundamental Metrics

Financial Performance
Metric
NPO
PTCT
Price
$315.71
$68.52
Analyst Decision
Buy
Buy
Analyst Count
3
17
Target Price
$278.33
$80.65
AVG Volume (30 Days)
235.2K
1.3M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
0.46%
N/A
EPS Growth
N/A
264.48
EPS
1.29
0.90
Revenue
$1,532,000,000.00
$264,734,000.00
Revenue This Year
$12.31
N/A
Revenue Next Year
$6.39
$17.70
P/E Ratio
$243.09
N/A
Revenue Growth
16.98
36.19
52 Week Low
$202.00
$43.18
52 Week High
$390.42
$90.87

Technical Indicators

Market Signals
Indicator
NPO
PTCT
Relative Strength Index (RSI) 45.00 28.53
Support Level $311.51 $68.16
Resistance Level $324.19 $72.09
Average True Range (ATR) 13.61 3.19
MACD -2.35 -1.23
Stochastic Oscillator 49.07 24.59

Price Performance

Historical Comparison
NPO
PTCT

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: